[1] Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge[J]. Int J Stroke, 2021, 16: 217-221. [2] Zhang HX, Wu J, Wu JH, et al. Exosome-mediated targeted delivery of miR-210 for angiogenic therapy after cerebral ischemia in mice[J]. J Nanobiotechnology, 2019, 17: 29. doi: 10.1186/s12951-019-0461-7. [3] Thulin Å, Lindbäck J, Granger CB, et al. Extracellular vesicles in atrial fibrillation and stroke[J]. Thromb Res, 2020, 193: 180-189. [4] Théry C, Witwer KW, Aikawa E, et al.Minimal information for studies of extracellular vesicles 2018 (MISEV2018):a position statement of the international society for extracellular vesicles and update of the MISEV2014 guidelines[J]. J Extracell Vesicles, 2018, 7: 1535750. doi: 10.1080/20013078.2018.1535750. [5] Purushothaman A. Exosomes from cell culture-conditioned medium: isolation by ultracentrifugation and characterization[J]. Methods Mol Biol, 2019, 1952: 233-244. [6] Xie J, Wu C. Ultrasensitive quantification of extracellular vesicles through dual signal amplification for the early diagnosis and prognosis of chronic obstructive pulmonary disease (COPD)[J]. Anal Methods, 2021. doi: 10.1039/d1ay01294k. [7] Ruf J, Vairo D, Paganelli F, et al. Extracellular vesicles with ubiquitinated adenosine A2A receptor in plasma of patients with coronary artery disease[J]. J Cell Mol Med, 2019, 23: 6805-6811. [8] Liu L, Zhang H, Mao H, et al. Exosomal miR-320d derived from adipose tissue-derived MSCs inhibits apoptosis in cardiomyocytes with atrial fibrillation (AF)[J]. Artif Cells Nanomed Biotechnol, 2019, 47: 3976-3984. [9] Xiao CT, Lai WJ, Zhu WA, et al. MicroRNA derived from circulating exosomes as noninvasive biomarkers for diagnosing renal cell carcinoma[J]. Onco Targets Ther, 2020, 13: 10765-10774. [10] Mazzeo A, Beltramo E, Lopatina T, et al. Molecular and functional characterization of circulating extracellular vesicles from diabetic patients with and without retinopathy and healthy subjects[J]. Exp Eye Res, 2018, 176: 69-77. [11] Mun D, Kim H, Kang JY, et al. Expression of miRNAs in circulating exosomes derived from patients with persistent atrial fibrillation[J]. FASEB J, 2019, 33: 5979-5989. [12] Wang S, Min J, Yu Y, et al. Differentially expressed miRNAs in circulating exosomes between atrial fibrillation and sinus rhythm[J]. J Thorac Dis, 2019, 11: 4337-4348. [13] Siwaponanan P, Keawvichit R, Udompunturak S, et al. Altered profile of circulating microparticles in nonvalvular atrial fibrillation[J]. Clin Cardiol, 2019, 42: 425-431. [14] Mørk M, Andreasen JJ, Rasmussen LH, et al. Elevated blood plasma levels of tissue factor-bearing extracellular vesicles in patients with atrial fibrillation[J]. Thromb Res, 2019, 173: 141-150. [15] Wang S, Li L, Hu X, et al. Effects of atrial fibrillation-derived exosome delivery of miR-107 to human umbilical vein endothelial cells[J]. DNA Cell Biol, 2021, 40: 568-579. [16] Hou PP, Luo LJ, Chen HZ, et al. Ectosomal PKM2 promotes HCC by inducing macrophage differentiation and remodeling the tumor microenvironment[J]. Mol Cell, 2020, 78: 1192-1206. [17] Wang Y, Jia L, Xie Y, et al. Involvement of macrophage-derived exosomes in abdominal aortic aneurysms development[J]. Atherosclerosis, 2019, 289: 64-72. [18] Wang H, Song NP, Li JP, et al. The microvesicle/CD36 complex triggers a prothrombotic phenotype in patients with non-valvular atrial fibrillation[J]. J Cell Mol Med, 2020, 24: 7331-7340. [19] Wang H, Yan HM, Tang MX, et al. Increased serum levels of microvesicles in nonvalvular atrial fibrillation determinated by ELISA using a specific monoclonal antibody AD-1[J]. Clin Chim Acta, 2010, 411: 1700-1704. [20] Meng H, Kou J, Ma R, et al. Prognostic implications and procoagulant activity of phosphatidylserine exposure of blood cells and microparticles in patients with atrial fibrillation treated with pulmonary vein isolation[J]. Mol Med Rep, 2017, 16: 8579-8588. [21] Liu D, Kou X, Chen C, et al. Circulating apoptotic bodies maintain mesenchymal stem cell homeostasis and ameliorate osteopenia via transferring multiple cellular factors[J]. Cell Res, 2018, 28: 918-933. [22] Tian Y, Zhu P, Liu S, et al. IL-4-polarized BV2 microglia cells promote angiogenesis by secreting exosomes[J]. Adv Clin Exp Med, 2019, 28: 421-430. [23] Yang L, Han Y, Nilsson-Payant BE, et al. A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids[J]. Cell Stem Cell, 2020, 27: 125-136. |